Effects of in vitro azithromycin treatment on bronchial epithelial antiviral immunity in asthma phenotypes
{{output}}
Background: Azithromycin (AZM) effectively reduces asthma exacerbations and enhances bronchial epithelial cell (BEC) antiviral immunity in vitro. However, its clinical impact on different asthma phenotypes is not fully elucidated... ...
